SCBio
PrivateLast Round
Series B
Sep 1, 2025
Total Funding Raised
$22.6M
Company Overview
SCBio is a pharmaceutical company that discovers and develops novel therapeutics with a focus on immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
immuno-oncologysmall molecule drugsdrug discoverytargeted cancer therapypreclinical biotechI-O therapypreclinical developmentoncology therapeuticsCD73 targetSirt6 targetbiotech out-licensingKorea Drug Development FundKDDF
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SCBio Comps
Public and private peers based on sector, stage, and business model.
SCBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 1, 2025 | ||||
| Series A | May 18, 2023 | ||||
| Pre Seed | Aug 19, 2022 |
SCBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Pre Seed |
| Korea University Holdings | Pre Seed |
| A Ventures | Series A |
| SL Investment | Series B |
| iM Investment Partners | Series B |
| Xquared | Series B |
| TS Investment | Series A |
SCBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SCBio's valuation, stock price, and market status.
